title: [The expression of nm23-H1 genes with clinical prognosis in endometrial carcinoma].
abstract: OBJECTIVE
  To study the expression of nm23-H1 gene in endometrial carcinoma and its relationships between the clinicopathological parameter and prognosis of endometrial carcinoma.
  
  
  METHODS
  The endometrial specimens of 60 cases with endometrial carcinoma were studied retrospectively by immunohistochemical stainings.
  
  
  RESULTS
  The positive expression rate of nm23-H1 gene in endometrial carcinoma was 55.0% (33/60). The positive rate of nm23-H1 in early endometrial carcinoma was significantly higher than that in advanced cases (65.9% and 25.0%, respectively, P < 0.05). Positive rates in the well and moderately differentiated endometrial carcinoma were also higher than those of poorly differentiated (66.7%, 63.6%, 29.4%, P < 0.05). 20.0% of the cases with and 64.9% of the cases without lymph node metastasis showed positive for nm23-H1 (P < 0.05). The expression of nm23-H1 was not correlated with histological type, myometrial invasion, estrogen receptor and progesterone receptor. The survival rate of patients with nm23-H1 expression was significantly higher than that of patients without nm23-H1 expression. The 5-year survival rate was 90.5% and 55.3% respectively (P < 0.05).
  
  
  CONCLUSIONS
  nm23-H1 gene may play a role in the inhibitory effect on the development and the lymph node metastasis of endometrial carcinoma, and may be related to be prognosis of endometrial carcinoma.
authors.affiliation: Frist Hospital Baotou Medical College, Baotou 014010.
authors.forename: C
authors.initials: C
authors.lastname: Guo
authors.forename: L
authors.initials: L
authors.lastname: Wei
authors.forename: Q
authors.initials: Q
authors.lastname: Fu
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000378:metabolism / Q000556:secondary; D018196:Carcinoma, Adenosquamous / Q000235:genetics / Q000378:metabolism / Q000556:secondary; D016889:Endometrial Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D005260:Female; D015870:Gene Expression; D006801:Humans; D008207:Lymphatic Metastasis; D020559:Monomeric GTP-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics; D054778:NM23 Nucleoside Diphosphate Kinases; D009701:Nucleoside-Diphosphate Kinase; D011379:Prognosis; D012189:Retrospective Studies; D014157:Transcription Factors / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D054778:NM23 Nucleoside Diphosphate Kinases; D014157:Transcription Factors; C517938:NME1 protein, human; D009701:Nucleoside-Diphosphate Kinase; D020559:Monomeric GTP-Binding Proteins